<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-19940" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Contraception</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bansode</surname>
            <given-names>Oshin M.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sarao</surname>
            <given-names>Manbeer S.</given-names>
          </name>
          <aff>Griffin Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Cooper</surname>
            <given-names>Danielle B.</given-names>
          </name>
          <aff>LSU Health Sciences Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Oshin Bansode declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Manbeer Sarao declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Danielle Cooper declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-19940.s1" sec-type="Definition/Introduction">
        <title>Definition/Introduction</title>
        <p content-type="pubmed-excerpt">Contraception is the act of preventing pregnancy.&#x000a0; This can be a device, a medication, a procedure or a behavior.&#x000a0; Contraception allows a woman control of her reproductive health and affords the woman the ability to be an active participant in her family planning.&#x000a0; This review will not address abortion as that is not a way to prevent a pregnancy from occurring.&#x000a0; Contraceptive methods are technological advances intended to overcome biology.&#x000a0; The 20 century has seen the biggest advancements for female reproductive health expanding medical options, devices, and even procedures.&#x000a0; This review will focus on medications, devices, and procedures available to couples to prevent pregnancy.&#x000a0; It will not focus on behaviors and barrier methods available.&#x000a0;</p>
        <p>When considering contraceptive methods counseling should include efficiency, safety, acceptability and availability (including accessibility and affordability). Voluntarily informing the choice of contraceptive methods is an important guiding principle, and contraceptive counseling, when associable, is a marked contributor to the successful use of contraceptive methods.</p>
        <p>Birth control methods are designed to prevent conception or interrupt or nullify implantation and growth. Conception can be prevented by hormonally disrupting the menstrual cycle (Oral contraceptive (OC) pills), by physically blocking the passageway (barrier methods or sterilization), or less successfully, by abstinence during fertile periods or withdrawal&#x000a0;method. Implantation is impaired via the use of a foreign body (intrauterine device {IUD}) or surgical removal (Salpingectomy or Vasectomy)<xref ref-type="bibr" rid="article-19940.r1">[1]</xref>.</p>
        <p>Contraception is best reviewed with the patient when efficacy is the top priority.&#x000a0; The following are ordered by the most effective form of contraception to the least effective:</p>
        <list list-type="bullet">
          <list-item>
            <p>Etonogestrel contraceptive Implant</p>
          </list-item>
          <list-item>
            <p>Levonorgestrel intrauterine system (LNG IUD)</p>
          </list-item>
          <list-item>
            <p>Copper intrauterine device (IUD)</p>
          </list-item>
          <list-item>
            <p>Female sterilization</p>
          </list-item>
          <list-item>
            <p>Vasectomy</p>
          </list-item>
          <list-item>
            <p>Injectables</p>
          </list-item>
          <list-item>
            <p>Combined oral contraceptives</p>
          </list-item>
          <list-item>
            <p>Progestin-only pill</p>
          </list-item>
          <list-item>
            <p>Patch</p>
          </list-item>
          <list-item>
            <p>Hormonal vaginal contraceptive ring</p>
          </list-item>
          <list-item>
            <p>Lactational Amenorrhea</p>
          </list-item>
          <list-item>
            <p>Diaphragm or cervical cap</p>
          </list-item>
          <list-item>
            <p>Sponge</p>
          </list-item>
          <list-item>
            <p>Male condom</p>
          </list-item>
          <list-item>
            <p>Female condom</p>
          </list-item>
          <list-item>
            <p>Spermicides</p>
          </list-item>
          <list-item>
            <p>Fertility awareness-based methods</p>
          </list-item>
          <list-item>
            <p>Withdrawal</p>
          </list-item>
          <list-item>
            <p>Emergency Contraception</p>
          </list-item>
          <list-item>
            <p>Copper IUD</p>
          </list-item>
          <list-item>
            <p>Emergency contraceptive pills</p>
          </list-item>
        </list>
        <p>Medical devices used to prevent pregnancy include intrauterine devices or subdermal implants.&#x000a0; The intrauterine device may or may not contain progesterone, and the subdermal implants all contain progesterone.&#x000a0; These devices are commonly referred to as Long Acting Reversible Contraceptives or LARCs.&#x000a0; The failure rate associated with the various forms of devices is less than 1 woman per 100 women per year making them the most effective form of contraception available, rates that are considered better than surgical sterilization.&#x000a0; There are few absolute contraindications and relate to uterine anatomic defects or allergy to the medication.&#x000a0; Contraceptive procedures involve surgical sterilization of the male and or female.&#x000a0; The least invasive is a vasectomy, and then tubal occlusion methods follow.&#x000a0; Hysteroscopic sterilization is no longer a practiced method at this time.&#x000a0; Procedures are intended to be permanent although surgical reversals are possible.&#x000a0; Failure rates are slightly higher than LARC methods but still, less than 1 woman per 100 women per year fails these surgical procedures.</p>
        <p>The injectable currently on the market is a progesterone only, it does not have an estrogen component and many times results in irregular bleeding.&#x000a0; Progesterone only forms alter cervical mucus and endometrial lining preventing conception.&#x000a0; The injections are every 12 week and the failure rate is 6 women per 100 women per year.&#x000a0;</p>
        <p>The medications commonly thought of for contraception include combined hormonal pills, patches, rings, and progesterone only pills.&#x000a0; Combined oral contraceptive pills are monophasic, biphasic and triphasic. They are dispensed monthly, quarterly or annual medications.&#x000a0; The common combined oral contraceptive pill mimics the menstrual cycle, 21-24 days of estrogen and progesterone to suppress ovulation, alter cervical mucus and the endometrial lining preventing pregnancy and 5-7 days of placebo resulting in an observed menses.&#x000a0; Continuous contraceptive pills use an 84-day continuous exposure of active phase pills and 7 days of placebo, or 365 days of active pills.&#x000a0; These forms are equally efficacious and share failure rates regardless of the format.&#x000a0; The combined hormonal patch and contraceptive ring offer a different entry point for the medication avoiding first pass effect and decreasing some side effects.&#x000a0; The patch is changed weekly with a placebo week to mimic routine menses. &#x000a0;The vaginal ring inserts for 3 weeks then removed for a placebo week to mimic menses.&#x000a0; These formulations all provide the same failure rates of 9 per 100 women per year.&#x000a0; A complete medical history and physical should be performed before starting any form of contraception as there may be relative and absolute contraindications.&#x000a0; The CDC offers a medical eligibility criteria for contraceptive use based on the chosen form of contraception and patient medical conditions and is easily accessed by physicians and patients.</p>
      </sec>
      <sec id="article-19940.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>Concerns arise in women who take hormone-based birth control as they have an increased incidence of breast cancer, making the contraceptives&#x000a0;a significant public health&#x000a0;priority.&#x000a0;In a recent study, M&#x000f8;rch et al. showed that&#x000a0;hormonal contraception had a 20% higher risk of breast cancer, regardless of the dose of estrogen, than women who never used any birth control methods&#x000a0;<xref ref-type="bibr" rid="article-19940.r2">[2]</xref>.&#x000a0;</p>
        <p>Irregular bleeding is a common side effect and patients should be counseled accordingly based on the form of medication or device they choose.&#x000a0;Contraceptive-induced menstrual bleeding changes (CIMBCs) should be recognized as a critical concern in contraceptive counseling and&#x000a0;usage&#x000a0;<xref ref-type="bibr" rid="article-19940.r3">[3]</xref>.</p>
        <p>IUD&#x02019;s are being utilized more frequently in the US.&#x000a0; &#x000a0;They provide excellent contraception with few side effects and are rarely contraindicated based on a patient&#x02019;s medical history.&#x000a0; Pelvic infection is possible, but the highest risk is within 20 days from insertion.&#x000a0; If a woman contracts a sexually transmitted infection first line is to just treat the infection, removal of the IUD is only considered if the patient fails therapy.&#x000a0; The key to minimizing problems in contraceptive practice is the consideration of sustainability (efficiency, cost, duration of action and suitability), making a careful and correct choice, and then counseling the patient well&#x000a0;<xref ref-type="bibr" rid="article-19940.r4">[4]</xref>.</p>
        <p>Venous thromboembolism (VTE) and arterial thrombosis (AT) are the most concerning side effects of the OC pill. The rate of VTE in non-pregnant women is 4-5 per 10,000, in OC pill users&#x000a0;is 9-10 in 10,000, while in a normal pregnancy it is approximately 30 in 10,000&#x000a0;<xref ref-type="bibr" rid="article-19940.r5">[5]</xref>.&#x000a0;Using a lower dose of estrogen may be better for preventing myocardial infarction and possibly thrombotic stroke.&#x000a0;The decision to use hormonal contraceptives and the choice of the formulation should be individualized based on the known risk factors and the patient's age and smoking status&#x000a0;<xref ref-type="bibr" rid="article-19940.r6">[6]</xref>.</p>
        <p>The number of children desired per family averages around&#x000a0;two in the United States. Despite the number of available options, close to 50% of pregnancies in the United States are not planned, and approximately 25% of babies born are unwanted at the time of birth&#x000a0;<xref ref-type="bibr" rid="article-19940.r1">[1]</xref>.</p>
      </sec>
      <sec id="article-19940.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Effective contraception provides social and health benefits to mothers and their children by reducing unintended pregnancies and abortions and facilitating family planning. Effective contraception indirectly helps in improving the&#x000a0;overall health status of infants and children.</p>
        <p>In addition to preventing pregnancy, the correct and consistent use of male condoms (a barrier method) reduces the risk of HIV and other STDs including infections like chlamydia, gonococcus, and trichomoniasis. Although hormonal contraceptives and IUDs are highly effective at preventing pregnancy, they do not protect against STDs, including HIV.</p>
        <p>Contraceptives&#x000a0;like OC pills are used clinically to treat <xref ref-type="bibr" rid="article-19940.r7">[7]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Primary dysmenorrhea</p>
          </list-item>
          <list-item>
            <p>Endometriosis</p>
          </list-item>
          <list-item>
            <p>Amenorrhea&#x000a0;due to low weight, stress or exercise</p>
          </list-item>
          <list-item>
            <p>Menstrual cramps</p>
          </list-item>
          <list-item>
            <p>Premenstrual syndrome</p>
          </list-item>
          <list-item>
            <p>Primary ovarian insufficiency</p>
          </list-item>
          <list-item>
            <p>Menorrhagia</p>
          </list-item>
          <list-item>
            <p>Acne</p>
          </list-item>
          <list-item>
            <p>Polycystic ovary&#x000a0;syndrome</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19940.s4">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19940&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19940">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/19940/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=19940">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-19940.s5">
        <title>References</title>
        <ref id="article-19940.r1">
          <label>1</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Hatcher</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Kowal</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <chapter-title>Birth Control</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Walker</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Hurst</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <source>Clinical Methods: The History, Physical, and Laboratory Examinations</source>
            <edition>3rd</edition>
            <publisher-name>Butterworths</publisher-name>
            <publisher-loc>Boston</publisher-loc>
            <year>1990</year>
            <pub-id pub-id-type="pmid">21250126</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19940.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>M&#x000f8;rch</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Skovlund</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Hannaford</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Iversen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fielding</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lidegaard</surname>
                <given-names>&#x000d8;</given-names>
              </name>
            </person-group>
            <article-title>Contemporary Hormonal Contraception and the Risk of Breast Cancer.</article-title>
            <source>N Engl J Med</source>
            <year>2017</year>
            <month>Dec</month>
            <day>07</day>
            <volume>377</volume>
            <issue>23</issue>
            <fpage>2228</fpage>
            <page-range>2228-2239</page-range>
            <pub-id pub-id-type="pmid">29211679</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19940.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Polis</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Hussain</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Berry</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>There might be blood: a scoping review on women's responses to contraceptive-induced menstrual bleeding changes.</article-title>
            <source>Reprod Health</source>
            <year>2018</year>
            <month>Jun</month>
            <day>26</day>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>114</fpage>
            <pub-id pub-id-type="pmid">29940996</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19940.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allen</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Contraception - common issues and practical suggestions.</article-title>
            <source>Aust Fam Physician</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>41</volume>
            <issue>10</issue>
            <fpage>770</fpage>
            <page-range>770-2</page-range>
            <pub-id pub-id-type="pmid">23210098</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19940.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reid</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Leyland</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Wolfman</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Allaire</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Awadalla</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Best</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dunn</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lemyre</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marcoux</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Menard</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Potestio</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rittenberg</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Senikas</surname>
                <given-names>V</given-names>
              </name>
              <collab>Society of Obstetricians and Gynaecologists of Canada</collab>
            </person-group>
            <article-title>SOGC clinical practice guidelines: Oral contraceptives and the risk of venous thromboembolism: an update: no. 252, December 2010.</article-title>
            <source>Int J Gynaecol Obstet</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>112</volume>
            <issue>3</issue>
            <fpage>252</fpage>
            <page-range>252-6</page-range>
            <pub-id pub-id-type="pmid">21416656</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19940.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lalude</surname>
                <given-names>OO</given-names>
              </name>
            </person-group>
            <article-title>Risk of cardiovascular events with hormonal contraception: insights from the Danish cohort study.</article-title>
            <source>Curr Cardiol Rep</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>15</volume>
            <issue>7</issue>
            <fpage>374</fpage>
            <pub-id pub-id-type="pmid">23715878</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19940.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Proctor</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Farquhar</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Combined oral contraceptive pill (OCP) as treatment for primary dysmenorrhoea.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2001</year>
            <issue>4</issue>
            <fpage>CD002120</fpage>
            <pub-id pub-id-type="pmid">11687142</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
